
- Mount Sinai Doctors
- Treats Adults
- Video Visit Available
- Accepting New Patients
Charles A Powell, MD, MBA
Pulmonary Medicine (Lung), Sleep Medicine
About Me
Charles A. Powell, MD, MBA is Professor of Medicine, and System Division Chief for Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai. He received his medical degree from University of Chicago and trained in Internal Medicine at Columbia University and in Pulmonary and Critical Care Medicine at Boston University. The primary focus of Dr. Powell’s clinical and research activities are lung nodules and cancer. Dr. Powell is NIH funded, has published over 150 articles, and directs an NIH funded translational sciences laboratory that examines the genomics of lung cancer. A particular area of focus is on deconvoluting the biology and genomics of early-stage lung adenocarcinoma for which recent advances have modified the diagnosis and approach to these tumors. He also directs research programs focused on applications of machine learning and artificial intelligence to advance diagnosis and treatment of respiratory diseases.
Dr. Powell is the CEO of the Mount Sinai Respiratory Institute that brings together leading expertise in diagnosing and treating all forms of respiratory illness and lung disease, including asthma, lung cancer, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD) and bronchiectasis.
He was the founding chair of the American Thoracic Society Assembly on Thoracic Oncology and he sees patients in consultation regarding lung nodules and lung cancer. Dr Powell’s international reputation in the field is demonstrated by his election as President of the Fleischner Society and by his leadership roles in the International Society of Respiratory Disease. He is chair of the International Multidisciplinary Adjudication Committee to evaluate interstitial lung disease adverse events in cancer clinical trials of antibody-drug conjugates that are sponsored by Daiichi Sankyo Inc. and Astra Zeneca Ltd.
The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.
Language
English
Position
DIRECTOR, MOUNT SINAI-NATIONAL JEWISH HEALTH RESPIRATORY INSTITUTE, PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET]
Clinical Focus
- Bronchoscopy, Diagnostic
- COVID-19 Lung Disease
- Lung Cancer
- Lung Mass
Video
Education
MD, University of Chicago Pritzker School of Medicine
Residency, Internal Medicine
Columbia Presbyterian Medical Center
Fellowship, Pulmonary and Critical Care Medicine
Boston University Medical Center
Certifications
American Board of Internal Medicine
Research
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VillageCareMax
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Transcriptional regulatory network analysis identifies GRN as a key regulator bridging chemotherapy and immunotherapy response in small cell lung cancer. Seungyeul Yoo, Ayushi S. Patel, Sarah Karam, Yi Zhong, Li Wang, Feng Jiang, Ranran Kong, Sharon Bikvan, Wenhui Wang, Abhilasha Sinha, Charles A. Powell, Jun Zhu, Hideo Watanabe. Journal of Hematology and Oncology
- OM-85, a Bacterial Lysate, Reduces Pulmonary Nodule Malignant Probability: A Retrospective Study. Mengting Sun, Yuqing Ni, Xueling Wu, Hao Tian, Yijun Song, Yinzhou Feng, Yunxin Guo, Yong Zhang, Jun Yin, Charles A Powell, Chunxue Bai, Yuanlin Song, Dawei Yang. Clinical Respiratory Journal
- The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models. Ling Cai, Fangjiang Wu, Qinbo Zhou, Ying Gao, Bo Yao, Ralph J. DeBerardinis, George K. Acquaah-Mensah, Vassilis Aidinis, Jennifer E. Beane, Shyam Biswal, Ting Chen, Carla P. Concepcion-Crisol, Barbara M. Grüner, Deshui Jia, Robert A. Jones, Jonathan M. Kurie, Min Gyu Lee, Per Lindahl, Yonathan Lissanu, Corina Lorz, David MacPherson, Rosanna Martinelli, Pawel K. Mazur, Sarah A. Mazzilli, Shinji Mii, Herwig P. Moll, Roger A. Moorehead, Edward E. Morrisey, Sheng Rong Ng, Matthew G. Oser, Arun R. Pandiri, Charles A. Powell, Giorgio Ramadori, Mirentxu Santos, Eric L. Snyder, Rocio Sotillo, Kang Yi Su, Tetsuro Taki, Kekoa Taparra, Phuoc T. Tran, Yifeng Xia, J. Edward van Veen, Monte M. Winslow, Guanghua Xiao, Charles M. Rudin, Trudy G. Oliver, Yang Xie, John D. Minna. Cancer Research
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Powell during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Bristol-Myers Squibb
- Duality Biologics
- Astrazeneca
- BioNTech
- Clario
- Daiichi Sankyo
- OnCusp Therapeutics
- Merus N.V.
- Animate Biosciences
- Aptar
- Pfizer Inc., U.S. Pharmaceuticals Group
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Animate Biosciences
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.